Results 31 to 40 of about 2,346,296 (295)
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2
Tocilizumab is an IL‐6 receptor antagonist with the ability to suppress the cytokine storm in critically ill patients infected with severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2).
Russell M. Petrak +25 more
doaj +1 more source
Indonesian Journal of Tropical and Infectious Disease
doaj +5 more sources
Heavy Schistosomiasis Associated With Poor Short-Term Memory and Slower Reaction Times in Tanzania Schoolchildren [PDF]
Cross-sectional studies of the relationship between helminth infection and cognitive function can be informative in ways that treatment studies cannot.
Department for Infectious Disease Epidemiology,Imperial College Shool of Medicine,London, Department for Infectious Disease
core
Metabolite changes in blood predict the onset of tuberculosis
Immunogenetics and cellular immunology of bacterial infectious ...
Boom, W.H. +21 more
core +1 more source
ABSTRACT Background An international Delphi panel of experts developed consensus statements to delineate the circumstances where the risks of dexamethasone as an antiemetic do and do not outweigh its benefits. Procedure Experts in supportive care of pediatric patients were invited to participate.
Negar Shavandi +20 more
wiley +1 more source
Macrolides: A Canadian Infectious Disease Society Position Paper
Since the introduction of erythromycin in 1965, no new compounds from the macrolide antimicrobial class were licensed in Canada until the 1990s. Clarithromycin and azithromycin, since their introduction, have become important agents for treating a number
S McKenna +2 more
doaj +1 more source
The symptoms of many infectious diseases influence their host to withdraw from social activity limiting their own potential to spread. Successful transmission therefore requires the onset of infectiousness to coincide with a time when its host is ...
Bansal, Shweta +2 more
core +1 more source
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges +12 more
wiley +1 more source
Clinical Insights Into Hypercalcemia of Malignancy in Childhood
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley +1 more source
Prevention of infectious diseases in athletes. [PDF]
The sports medicine physician may face challenging issues regarding infectious diseases when dealing with teams or highly competitive athletes who have difficulties taking time off to recover.
d'Hemecourt, Pierre, Luke, Anthony
core

